Live Breaking News & Updates on Werner Haas

Stay updated with breaking news from Werner haas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

LimmaTech Biologics Reports Positive Interim Phase I/II Clinical Data on Tetravalent Shigella Bioconjugate Vaccine S4V

SCHLIEREN, Switzerland, February 22, 2024 LimmaTech Biologics AG announced positive interim data from its Phase I/II clinical trial evaluating Shigella4V (S4V), a tetravalent bioconjugate vaccine candidate against shigellosis, an infectious disease caused by Shigella bacteria. Shigellosis is a serious infection and remains the second leading cause of fatal diarrheal disease, particularly in infants in low- and middle-income countries. In the nine-month-old target population, administration of S ....

United Kingdom , Limmatech Biologics , Alexander Siebert , Patricia Martin , Franz Werner Haas , Network Meeting , Trophic Communications , Chief Operating Officer , Annual Network Meeting , Wellcome Trust , Gram Negative Shigella , Tech Biologics , Werner Haas , Clinical Trial , Vaccine Candidate , Diarrheal Disease , Tolerability Profile , Topline Results , Target Population , Clinical Development ,

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Franz Werner Haas , Paul Wolfrom , Alexander Siebert , Nicola Forrest , Limmatech Biologics , Steve Burnell , Stefan Klotter , Trophic Communications , Impact Fund , Novo Holdings , Adjuvant Capital , Chief Executive Officer , Managing Director , Chief Financial Officer , Tech Biologics , Werner Haas , Die Performance Strategie , Assets Sie ,

Record-breaking aerodynamics in 'flying lawn chairs', Blue Whales, and Dolphins from NSU

Record-breaking aerodynamics in 'flying lawn chairs', Blue Whales, and Dolphins from NSU
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Baden Wüberg , Bonneville Salt Flats , United States , Audi Mediacenter , Rupert Hollaus , Viktor Frankenberger , Werner Haas , Rennfox Dolphin , Wilhelm Herz , Rennmax Dolphin , Klaus Arth , Klasing Verlag , Edmund Rumpler , Gustav Adolf Baumm , Hermann Paul , Paul Jaray , Walter Froede , Horch Museum In Zwickau , Blue Whales , Adolf Baumm , Rennmax Blue Whale , Audi Tradition , Reinhard Freiherr , Blue Whale , World Championship , German Championship ,

LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc's Innovative Vaccine Candidate Against Staphylococcus aureus

LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc's Innovative Vaccine Candidate Against Staphylococcus aureus
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Gretchen Schweitzer , Javad Aman , Franz Werner Haas , Limmatech Biologics , Michael Kowarik , National Institutes Of Health , Biomedical Advanced Research , Development Authority , Impact Fund , Human Services , National Institute Of Allergy , Us National Institute Of Allergy , Germany Federal Ministry Of Education , Administration For Strategic Preparedness , World Health Organization , Trophic Communications , United Kingdom Global Antimicrobial Resistance Innovation Fund , Us Department Of Health , United Kingdom Government Department Of Health , Abvacc Inc , Novo Holdings , Tech Biologics , Chief Executive Officer , Chief Scientific Officer , National Institutes ,

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

SCHLIEREN, Switzerland, October 09, 2023 LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platform and accelerate its pipeline of preclinical and clinical vaccine candidates against increasingly dangerous bacterial infections, including programs addressing shigellosis and gonorr ....

United States , New York , City Of , United Kingdom , Alexander Siebert , Kabeer Aziz , Zina Affas Besse , Limmatech Biologics , Franz Werner Haas , Camilla Petrycer Hansen , Hooft Van Huijsduijnen , Limmatech Bio , Novo Holding , Principal At Novo Holdings , Impact Fund , National Overview , Infective Resistance Impact Fund , Novo Holdings , Novo Nordisk Foundation , World Health Organization , Trophic Communications , United States Centers For Disease , Adjuvant Capital , Affas Besse , Deputy Head , Private Equity ,